Importance of Growth for Health and Development

65th Nestlé Nutrition Institute Workshop, Pediatric Program, Kuala Lumpur, March 2009

Editor(s): Lucas A. (London) 
Makrides M. (Adelaide, S.A.) 
Ziegler E.E. (Iowa City, Iowa) 
Table of Contents
Vol. 65, No. , 2010
Section title: Growth and Neurological Development

Role of Long-Chain Polyunsaturated Fatty Acids in Neurodevelopment and Growth

Makrides M. · Smithers L.G. · Gibson R.A.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


There has been intense interest in the role of the n-3 long-chain polyunsaturated fatty acid (LCPUFA) docosahexaenoic acid (DHA, 22:6n-3), in growth and development of infants. In 2009, there are at least twelve published randomized controlled trials (RCT) assessing the effects of LCPUFA supplementation of infant formula for preterm infants and seventeen RCTs involving formula-fed term infants. In addition, at least five RCTs have investigated the effect of DHA supplementation during pregnancy and/or lactation on infant and early child development. Collectively, the published literature has demonstrated no harm of dietary LCPUFA for infants regardless of whether they are born preterm or at term. However, developmental benefit is more consistently observed in infants born preterm. This may be explained by the fact that DHA accretion to neural tissues peaks during the fetal brain growth spurt in the last trimester of pregnancy. Infants born preterm are denied the full gestation period to accumulate DHA and are at risk of incomplete DHA accumulation. New research is focused on the timing and dose of DHA supplementation needed to optimize developmental outcomes.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. McCann JC, Ames BN: Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005;82:281-295
  2. Uauy R, Birch D, Birch E, et al: Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr Res 1990;28:485-492
  3. Birch D, Birch E, Hoffman DR, et al: Retinal development of very low birthweight infants fed diets differing in n-3 fatty acids. Invest Ophthalmol Vis Sci 1992;33:2365-2376
  4. Carlson SE, Werkman SH, Rhodes PG, et al: Visual-acuity development in healthy preterm infants effect of marine-oil supplementation. Am J Clin Nutr 1993;58:35-42
  5. Carlson SE, Cooke RJ, Werkman SH, et al: First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992;27:901-907
  6. Makrides M, Gibson RA, Udell T, et al: Supplementation of infant formula with long-chain polyunsaturated fatty acids does not influence the growth of term infants. Am J Clin Nutr 2005;81:1094-1101
  7. Simmer KN, Patole SK, Rao SC: Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008;1:CD000376
  8. Simmer KN, Schulzke SM, Patole S: Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2008;1:CD000375
  9. Gibson RA, Makrides M: LCPUFA and the growth of preterm or term infants. A systematic review and meta-analysis Maternal and Infant LCPUFA Workshop, Kansas City, 2003;1-21
  10. Smithers LG, Gibson RA, McPhee A, et al: Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment a systematic review of randomized controlled trials. Am J Clin Nutr 2008;87:912-920
  11. Clandinin MT, Van Aerde JE, Merkel KL, et al: Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr 2005;146:461-468
  12. Fang PC, Kuo HK, Huang CB, et al: The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants. Chang Gung Med J 2005;28:708-715
  13. Fewtrell MS, Abbott RA, Kennedy K, et al: Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004;144:471-479
  14. Fewtrell MS, Morley R, Abbott RA, et al: Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics 2002;110:73-82
  15. O’Connor DL, Hall R, Adamkin D, et al: Growth and development in preterm infants fed long-chain polyunsaturated fatty acids a prospective randomized controlled trial. Pediatrics 2001;108:359-371
  16. Carlson SE: Lipid requirements of very-low-birth-weight infants for optimal growth and development. (eds) Dobbing J: Lipids, Learning, and the Brain Fats in Infant Formulas Columbus, Ross Laboratories, 1993;188-207
  17. van Wezel-Meijler G, van der Knapp MS, Huisman J, et al: Dietary supplementation of long-chain polyunsaturated fatty acids in preterm infants effects on cerebral maturation. Acta Paediatr 2002;91:942-950
  18. Auestad N, Halter R, Hall RT, et al: Growth and development in term infants fed long-chain polyunsaturated fatty acids A double-masked, randomized, parallel, prospective, multivariate study. Pediatrics 2001;108:372-381
  19. Birch E, Garfield S, Hoffman DR, et al: A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000;42:174-181
  20. Bouwstra H, Dijck-Brouwer AJ, Boehm G, et al: Long-chain polyunsaturated fatty acids and neurological developmental outcome at 18 months in healthy term infants. Acta Paediatr 2005;94:26-32
  21. Lucas A, Stafford M, Morley R, et al: Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk a randomised trial. Lancet 1999;354:1948-1954
  22. Makrides M, Neumann MA, Simmer K, et al: A critical appraisal of the role of dietary long-chain polyunsaturated fatty acids on neural indices of term infants a randomized controlled trial. Pediatrics 2000;105:32-38
  23. Scott DT, Janowsky J, Carroll RE, et al: Formula supplementation with long-chain polyunsaturated fatty acids are there developmental benefits?. Pediatrics 1998;102:e59
  24. Martinez M: Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-S138
  25. Oken E, Osterdal ML, Gillman MW, et al: Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood a study from the Danish National Birth Cohort. Am J Clin Nutr 2008;88:789-796
  26. Oken E, Radesky JS, Wright RO, et al: Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol 2008;167:1171-1181
  27. Mendez MA, Torrent M, Julvez J, et al: Maternal fish and other seafood intakes during pregnancy and child neurodevelopment at age 4 years. Public Health Nutr 2008;Epub ahead of print
  28. Hibbeln JR, Davis JM, Steer C, et al: Maternal seafood consumption in pregnancy and neurodevelopment outcomes in childhood (ALSPAC study) an observational cohort study. Lancet 2007;369:578-285
  29. Cheruku SR, Montgomery-Downs HE, Farkas SL, et al: Higher maternal plasma docosa-hexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002;76:608-613
  30. Colombo J, Kannass KN, Shaddy J, et al: Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev 2004;75:1254-1267
  31. Kanass KN, Colombo J, Carlson SE: Maternal DHA levels and toddler free play attention. Dev Neuropsychol 2009;34:1-16
  32. Krabbendam L, Bakker EC, Hornstra G, et al: Relationship between DHA status at birth and child problem behaviour at 7 years of age. Prostaglandins Leukot Essent Fatty Acids 2007;76:29-34
  33. Bakker EC, Hornstra G, Blanco CE, et al: Relationship between long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age. Eur J Nutr 2009;63:499-504
  34. Judge MP, Harel O, Lammi-Keefe CJ: Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 mo. Am J Clin Nutr 2007;85:1572-1577
  35. Tofail F, Kabir I, Hamadani JD, et al: Supplementation of fish-oil and soy-oil during pregnancy and psychomotor development of infants. J Health Popul Nutr 2006;24:48-56
  36. Dunstan JA, Simmer K, Dixon G, et al: Cognitive assessment at 2 1/2 years following fish oil supplementation in pregnancy a randomized controlled trial. Arch Dis Fetal Neonat Ed 2006;93:F45-F50
  37. Helland IB, Saugstad OD, Smith L, et al: Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108:1-10
  38. Helland IB, Smith L, Blomen B, et al: Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children’s IQ and body mass index at 7 years of age. Pediatrics 2008;122:e472-e479
  39. Helland IB, Smith L, Saarem K, et al: Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 2003;111:e39-e44
  40. Clandinin MT, Chappell JE, Heim T, et al: Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev 1981;5:355-366
  41. Makrides M, Gibson RA, McPhee A, et al: Neurodevelopmental outcome of preterm infants fed high-dose docosahexaenoic acid a randomized controlled trial. JAMA 2009;301:175-182
  42. Smithers LG, Gibson RA, McPhee A, et al: Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants results of a randomized controlled trial. Am J Clin Nutr 2008;88:1049-1056
  43. Henriksen C, Haugholt K, Lindgren M, et al: Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008;121:1137-1145
  44. Huang WL, King VR, Curran OE, et al: A combination of intravenous and dietary docosa-hexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007;130:3004-3019
  45. King VR, Huang WL, Dyall SC, et al: Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 2006;26:4672-4680
  46. Bailes J, Mills J, Wilson J, et al: Omega-3 fatty acid supplementation reduces the extent of axon damage after brain trauma. 8th Meet Int Soc Study Fatty Acids Lipids Kansas City, May 2008;

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00